Exhibit 4.14


 


	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 	 

     

     

    Valid
    until: October 20, 2022

    Dealer's
    Code: V-1315-060518



 


Initial
Authorization to Establish a Site for Dealing with a Controlled Substance


 


By
virtue of the authority vested in me pursuant to Sections 6, 7 and 13 in the middle of the Dangerous Drugs Ordinance [New Version], 5733
– 1973 (hereinafter “the Ordinance”) and pursuant to the Dangerous Drugs Regulations, 5739 – 1979 (hereinafter:
“the Regulations”), an initial authorization is hereby granted to establish a proliferation farm – proliferation of
cannabis plants (hereinafter “the site”) and, according to the following detail:


 


	1.	The
                                            Applicant for the Authorization and his Details:



 


	1.1
                                                                     Name of the entrepreneur/Corporation: Dalia Bezizinsky

    1.2
    Site Address: Kochav Michael

    1.3
    Contact Person (Name): Dalia Bezizinsky
	ID/Co
No: 054771613: (hereinafter: “the applicant”)

    Farm/Estate:
    Form Number 10

    ID
    No: 054771613 Tel No: 054-222-8861



 


	2.	Name
                                            of the Controlled Substance



 


CANNABIS


 


	3.	Its
                                            Form



 


This
approval does not constitute approval for possession in any form


It
is absolutely prohibited to possess the drug, plant, any part of it, its components or products and in any form for as long as no express
license for this is been received from the Director.


 


	4.	The
                                            Purpose of the Approval



 


		4.1	To
                                            act for planning/establishing/adapting a proliferation farm – proliferation of
                                            the cannabis plant



		4.2	The
                                            applicant declares that this approval will not be used for any purpose not approved and specified
                                            expressly in this approval.



 


	5.	Restrictions
                                            and Additional Conditions:



 


		5.1	This
                                            approval is only temporary. This approval can be annulled pursuant to the Director’s
                                            sole discretion, or pursuant to a Government of Israel decision, without derogating from
                                            any other cause in the law for annulling the approval.



		5.2	This
                                            approval contains nothing to impose any obligation whatsoever on the Ministry of Health or
                                            the Medical Cannabis Agency to grant a license for dealing in a controlled substance.



		5.3	This
                                            approval is approval for the applicant to commence establishing or adapting the site pursuant
                                            to the designated occupation. The principles of the planning and establishment/adaptation
                                            of the business must be executed pursuant to the designated occupation, while complying with
                                            all the relevant requirements of the law and pursuant to quality and security requirements
                                            as detailed below:



		a.	Cultivation
                                            or proliferation of the cannabis plants – as detailed in Procedure IMC-GAP (proper
                                            cultivation conditions) and as detailed in Procedure IMC GSP (security conditions).



 



It
must be emphasized: The applicant must comply with the security requirements as detailed in Procedure IMC-GSP at the site and must receive
security approval pursuant to the type of occupation.


 


		5.4	This
                                            approval cannot be transferred in any form whatsoever.



		5.5	Should
                                            there be any change whatsoever in the ownership of the applicant, or in the identity of the
                                            controlling shareholders therein, or in its managers or authorized signatories, who are detailed
                                            in this license without receiving the advance written approval of the IMCA for this –
                                            the validity of the license will expire. Regarding this section, a change in the ownership
                                            means transferring shares, in any manner whatsoever, in a volume that exceeds 5% of the Company’s
                                            total share capital.



 


[signature]


[stamp]
MGR Yuval Landschaft


L.N.
4023


Director


the
Medical Cannabis Agency (IMCA)





	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	 	Kol
                                            Habriut

    *5400
	 	[bilingual
    text see left column]


 




    	 



     


    

 


	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 	 

     

     

    Valid
    until: October 20, 2022

    Dealer's
    Code: V-1315-060518



 


		5.6	In
                                            view of the activity in the cannabis field, and because this activity obligates, inter alia,
                                            receipt of the IMCA’s approval for all the dealers, managers and interested parties
                                            in companies and/or their managers – granting the initial authorization/the license
                                            is subject to the attached conditions:




 


		a.	Any
                                            material shareholder as defined in the Company’s capital, 5759 – 1999 and/or
                                            controlling shareholder as defined in the Company’s capital 5759 – 1999 and/or
                                            any effective controlling shareholder and/or Director and/or General Manager in the Company,
                                            has to receive the IMCA’s approval.



		b.	No
                                            shares in the Company may be transferred to any offeree whatsoever when, following this allocation,
                                            he will become an interested party, prior to the IMCA’s approval for this after receiving
                                            a recommendation from a competent official.



		c.	No
                                            Director and/or General Manager may be appointed in the Company prior to receiving the IMCA’s
                                            approval for this, after receiving a recommendation from a competent official. This



		d.	The
                                            Company must amend its Articles of Association so that they include an instruction pursuant
                                            to which if any entity/entities whatsoever becomes/become an interested party/interested
                                            parties in the Company by virtue of his/their shareholding or an agreement between the shareholders,
                                            prior to receiving the mandatory approvals from the IMCA, the Company shall have the right
                                            to confiscate and/or make some of the shares held by one or more of these shareholders dormant
                                            so that after the confiscation and/or making the shares dormant the entity/entities will
                                            no longer be interested parties by virtue of the holdings or by virtue of agreement in the
                                            Company.



d1.
An entity/entities, whose shares have been made dormant, should they be made dormant, shall, at any time, have the right to sell or transfer
all or some of these shares to another/others, subject to the details in this Procedure and the requirements of the Ordinance and the
Law.


		e.	The
                                            Company will not extend the appointment of a Director or its General Manager, unless at the
                                            date of the extension there is approval from the IMCA in this regard, after receiving a repeat
                                            recommendation from a competent official.



		f.	At
                                            every Annual Meeting of the Company, the General Manager of the Company must declare that
                                            all the approval/approvals required from the IMCA for the Company, the manager/managers and
                                            the interested party/parties, as detailed in Sections a, b, and c above as at the date of
                                            the meeting, are available and valid and there has not been any change in the status of the
                                            Company, the managers/managers, material shareholder/shareholders and the interested party/parties
                                            from the date of being granted the authorization/authorizations



 


		5.7	The
                                            applicant must inform the Director immediately of any change in any of his details (his address,
                                            contact persons etc.) and must receive the IMCA’s advance written approval for any
                                            change in the ownership of the applicant or in the identity of the interested parties or
                                            its managers or its authorized signatories or the material shareholders.



		5.8	The
                                            presence of minors at the site or installation is absolutely prohibited.



		5.9	The
                                            instructions in the ordinance and regulations and any instruction and/or stipulation for
                                            complying with any of the quality conditions required shall apply to the applicant.



		5.10	The
                                            applicant must keep a regular record of all the actions regarding the establishment of the
                                            site and any additional record required by the Director.



The
records must be presented to the Director whenever he requires this and must also be presented to any other competent entity according
to the matter pursuant to the demand of the Director.


		5.11	These
                                            conditions and stipulations can be updated at the IMCA’s sole discretion and with approval
                                            of the Director General of the Ministry of Health. The IMCA is entitled to publish additional
                                            instructions pursuant to the circumstances and essence of the occupation.



 


	6.	The
                                            Validity of the Approval



 


		6.1	This
                                            approval annuls any other or additional previous approval in the possession of the applicant.



		6.2	This
                                            approval was granted on October 20, 2021 at the offices of the IMCA



		6.3	The
                                            validity of this approval expires on October 20, 2022, unless it is annulled
                                            previously to this at the decision of the Director.



 


Yuval
Landschaft


The
Director pursuant to the Dangerous Drugs Ordinance


 


[signature]


[stamp]
MGR Yuval Landschaft


L.N.
4023


Director


the
Medical Cannabis Agency (IMCA)





	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	 	Kol
                                            Habriut

    *5400
	 	[bilingual
    text see left column]